Disorders in cell circuitry during multistage carcinogenesis: The role of homeostasis

Carcinogenesis

Volumn 21, Issue 5, 2000, Pages 857-864

  Weinstein, I Bernard ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CELL CYCLE PROTEIN; COMPLEMENTARY DNA; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P27; RETINOBLASTOMA PROTEIN;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; COLON CARCINOGENESIS; FEEDBACK SYSTEM; GENE MUTATION; HOMEOSTASIS; NOTE; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0034066072     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.857     Document Type: Note

References (74)

1. Weinstein, I.B. (1988) The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Twenty-seventh G.H.A. Clowes memorial lecture. Cancer Res., 48, 4135-4143.
2. Weinstein, I.B. (1991) Cancer prevention: recent progress and future opportunities. Cancer Res., 51, 5080S-5085S.
3. Weinstein, I.B., Carothers, A.M., Santella, R.M. and Perera, F.P. (1995) Molecular mechanisms of mutagenesis and multistage carcinogenesis. In Mendelsohn, J., Howley, P.M., Israel, M.A. and Liotta, L.A. (eds) The Molecular Basis of Cancer. W.B. Saunders, Philadelphia, PA, pp. 59-85.
4. Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell, 61, 759-767.
5. Park, M. (1998) Oncogenes. In Vogelstein, B. and Kinzler, K.W. (eds) The Genetic Basis of Human Cancer. McGraw-Hill, New York, pp. 205-228.
6. Fearon, E.R. (1998) Tumor suppressor genes. In Vogelstein, B. and Kinzler, K.W. (eds) The Generic Basis of Human Cancer. McGraw-Hill, New York, pp. 229-236.
7. Hanahan D. and Weinberg, R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
8. Lengauer, C., Kinzler, K.W. and Vogelstein, B. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649.
9. Malkhosyan, S., Yasuda, J., Soto, J.L., Sekiya, T., Yokato, J. and Perucho, M. (1998) Molecular karyotype (amplotype) of metastatic colorectal cancer by unbiased arbitrarily primed PCR DNA fingerprinting. Proc. Natl Acad. Sci. USA, 17, 10170-10175.
10. Weinstein, I.B., Begemann, M., Zhou, P., Han, E.K.-H., Sgambato, A., Doki, Y., Arber, N. and Ciaparrone, M. and Yamamoto, H. (1997) Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. Clin. Cancer Res., 3, 2696-2702.
11. Weinstein, I.B. and Zhou, P. (1997) Defects in cell cycle control genes in human cancer. In Bertino, J.R. (ed.) Encyclopedia of Cancer. Academic Press, New York, Vol. 1, pp. 256-267.
12. Sgambato, A., Flamini, G., Cittadini, A. and Weinstein, I.B. (1998) Abnormalities in cell cycle control in cancer and their clinical implications. Tumori, 84, 421-433.
13. Han, E.K.-H., Rubin, M.A., Lim, J.T., Arber, N., Xing, W.-Q. and Weinstein, I.B. (1998) Cyclin D1 expression in human prostate cell lines and primary tumors. The Prostate, 35, 95-101.
14. Arber, N., Hibshoosh, H., Moss, S.F., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I.B. and Holt, P. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology, 110, 669-676.
15. Arber, N., Lightdale, C., Rotterdam, H., Finegold, J., Ahsan, H., Han, E.K.-H., Sgambato, A., Stevens, P.D., Green, P.H.R., Neugut, A.I., Holt, P.R. and Weinstein, I.B. (1996) Increased expression of the cyclin D1 gene in Barrett's Esophagus. Cancer Epidemiol. Biomarkers Prev., 3, 457-459.
16. Tetsu, O. and McCormick, F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 144, 422-426.
17. Shutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R. and Ben-Zeev, A. (1999) The cyclin D1 gene is a target of the β-catenin/Lef-1 pathway. Proc. Natl Acad. Sci. USA, 96, 5522-5527.
18. Galaktionov, K., Lee, A.K., Eckstein, J., Draetta, G., Meckler, J., Massimo L. and Beach, D. (1995) cdc25 phosphatases as potential human oncogenes. Science, 269, 1575-1577.
19. Wu., W., Fan, Y.-H., Kemp, B.L., Walsh, G. and Mao, L. (1998) Overexpresion of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res., 58, 4082-4085.
20. Gaspparotto, D., Maestro, R., Piccinin, S., Vukosavljevic, T., Barzan, L., Sulfaro, S. and Boiocchi, M. (1997) Overexpression of cdc25A and cdc25B in head and neck cancers. Cancer Res., 57, 2366-2368.
21. Yao, Y., Slosberg, E., Wang, L., Hibshoosh, H., Zhang, Y.-J., Xing, W.-Q., Santella, R.M. and Weinstein, I.B. (1999) Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice. Oncogene, 18, 5159-5166.
22. Zhou, P., Jiang, W., Zhang, Y.-J., Kahn, S.M., Schieren, I., Santella, R.M. and Weinstein, I.B. (1995) Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene, 11, 571-580.
23. Arber, N., Doki, Y., Han, E.K.-H., Sgambato, A., Zhou, P., Kim, N., Delohery, T., Klein, M.G., Holt, P.R. and Weinstein, I.B. (1997) Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res., 57, 1569-1574.
24. Kornmann, M., Danenberg, K.D., Arber, N., Beger, H.G., Danenberg, P.V. and Kore, M. (1999) Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res., 59, 3505-3511.
25. Sauter, E.R., Nesbit, M., Litwin, S., Klein-Szanto, J.-P., Cheffetz, S. and Herlyn, M. (1999) Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res., 59, 4876-4881.
26. Zhou, P., Jiang, W., Weghorst, C.M. and Weinstein, I.B. (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res., 56, 36-39.
27. Asano, K., Sakamoto, H., Sasaki, H., Ochiya, T., Yoshida, T., Ohishi, Y., Machida, T., Kakizoe, T., Sugimura, T. and Terada, M. (1995) Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem. Biophys. Res. Commun., 217, 1169-1176.
28. kipl protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis, 18, 1139-1148.
29. Kipl and its alterations in tumor cells. A review. J. Cell. Physiol., in press.
30. Kipl is haplo-insufficient for tumour suppression. Nature, 396, 177-180.
31. Han, E.K.-H., Sgambato, A., Jiang, W., Zhang, Y.-J., Santella, R.M., Doki, Y., Cacace, A., Schieren, I. and Weinstein, I.B. (1995) Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene, 10, 953-961.
32. Kipl inhibitor protein. Cancer Res., 56, 1389-1399.
33. KIPl expression. Cell Growth Differ., 8, 393-405.
34. Kipl in human breast cancers. Clin. Cancer Res., 3, 1879-1887.
35. Kipl in multistage colorectal carcinogenesis. Cancer Res., 58, 114-122.
36. Fredersdorf, S., Burns, J., Milne, A.M., Packham, G., Fallis, L., Gillet, C.E., Royds, J.A., Peston, D., Hall, P.A., Hanby, A.M., Barnes, D.M., Shousha, S., O'Hare, M.J. and Lu, X. (1997) High level expression of p27(kipl) and cyclin D1 in come human breast cancer cells: inverse correlation between the expression of p27(kipl) and degree of malignancy in human breast and colorectal cancers. Proc. Natl Acad. Sci. USA, 94, 6380-6385.
37. Kipl and cyclin E, alone or in combination, correlate with survival in young breast cancer patients. Nature Med., 3, 222-225.
38. Kipl protein: prognostic implications in primary breast cancer. Nature Med., 3, 227-230.
39. Kipl in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res., 58, 1042-1047.
40. Kipl inhibits the growth of both normal and transformed human mammary epithelial cells. Cancer Res., 58, 3448-3454.
41. Kipl inhibitor protein. Cancer Res., 56, 1389-1399.
42. Cipl/Wafl on growth and differentiation in human colon carcinoma cells. Oncogene, 18, 103-115.
43. Wildrick, D.M. and Boman, B.M. (1994) Does the human retinoblastoma gene have a role in colon cancer? Mol. Carcinog., 10, 1-7.
44. Yamamoto, H., Soh, J.-W., Klein, M.G., Zhang, L.-M., Schieren, I., Stein, C.A. and Weinstein, I.B. (1999) Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. Clin. Cancer Res., 5, 1805-1815.
45. Muller, H., Lucas, J., Schneider, A., Warthtoe, P., Bartek, J., Eilers, M. and Strauss, M. (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad. Sci. USA, 91, 2945-2949.
46. Lemass, H., Ryan, E., Mathuna, P.M., Crowe, J. and O'Keane, J.C. (1998) Elevated pRB is associated with elevated E2F-1 but not cyclin D1 or cyclin dependent kinase 4 in the colorectal carcinomas cell cycle. Gastroenterology (Am. Gastroenterol. Assoc. Abstr.), 114, G2612.
47. Haas-Kogan, D.A., Kogan, S.C., Levi, D., Dazin, P., T'Ang, A., Fung, Y.K. and Israel, M.A. (1995) Inhibition of apoptosis by the retinoblastoma gene product. EMBO J., 14, 461-472.
48. Zwicker, J., Liu, N., England, K., Lucibello, F.C. and Muller, R. (1996) Cell cycle regulation of E2F site occupation in vivo. Science, 271, 1595-1597.
49. Li., Y., Michael, A., Nichols, J., Shay, J.W. and Xiong, Y. (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene produce pRb. Cancer Res., 54, 6078-6082.
50. Otterson, G.A., Kratzke, R.A., Coxon, A., Kim, Y.W. and Kaye, F.J. (1994) Absence of pl6INK4 protein is restricted to the subset of lung cancer lines that retains wild-type R.B. Oncogene, 9, 3375-3378.
51. WAFI/CIP1 in human brain tumors. Oncogene, 1, 2021-2028.
52. Marchetti, A., Doglioni, C., Barbareschi, M., Buttitta, F., Pellegrini, S., Bertacca, G., Chella, A., Merlo, G., Angeletti, C.A., Palma, P.D. and Bevilacqua, G. (1996) p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene, 12, 1319-1324.
53. WAFI/CIPI in normal, hyperplastic and neoplastic uterine tissues. Hum. Pathol., 28, 60-66.
54. WAFl immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status. MIB1 expression, p53 gene and protein alterations and relapse-free survival. Br. J. Cancer, 74, 208-215.
55. Gansauge, S., Gansauge, F., Ramadani, M., Stobbe, H., Rau, B., Harada, N. and Beger, H.G. (1997) Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res., 57, 1634-1637.
56. Himaya, H., Iavarone, A., LaBaer, J. and Reeves, S. (1997) Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene, 14, 2533-2542.
57. INK4B1. Cancer Res., 56, 722-727.
58. Easton, J., Wei, T., Lahti, J.M. and Kidd, V.J. (1998) Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblasloma. Cancer Res., 58, 2624-2632.
59. Chen, X., Bargpmetto, J. and Prives, C. (1995) p53 through p21 (WAF1/CIPI). induces cyclin D1 synthesis. Cancer Res., 55, 4257-4263.
60. Evan, G. and Littwood, T. (1998) A matter of life and death. Science, 281, 1317-1326.
61. Han, E.K.-H., Ng, S.C., Arber, N., Begemann, M. and Weinstein, I.B. (1999) Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis. Apoptosis, 4, 213-219.
62. Cacace, A., Ueffing, M., Phillip, A., Han, E.K.-H., Kolch, W. and Weinstein, I.B. (1996) PKC epsilon functions as an oncogene by activating the RAF kinase. Oncogene, 13, 2517-2526.
63. Soh, J.-W., Lee, E.H., Prywes, R. and Weinstein, I.B. (1999) Novel roles of specific isoforms of protein kinase C in activation of the c-fos serum response element. Mol. Cell. Biol., 19, 1313-1325.
64. Bhalla, S. and Iyengar, R. (1999) Emergent properties of networks of biological signaling pathways. Science, 283, 381-390.
65. Kohn, K.W. (1998) Functional capabilities of molecular network components controlling the mammalian cell cycle phase transition. Oncogene, 16, 1065-1075.
66. Hartwell, L.H., Hopfield, J.J., Leibler, S. and Murray, A.W. (1999) From molecular to modular cell biology. Nature, 402, C47-C52.
67. Takahashi, T., Carbone, D., Takahashi, T., Nau, M.M., Hida, T., Linnoila, I., Ueda, R. and Minna, J.D. (1992) Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res., 52, 2340-2343.
68. Li, J., Hu, S.-X., Perng, G.-S., Zhou, Y., Xu, K., Zhang, C., Seigne, J., Benedict, W.F. and Xu, H-J. (1996) Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. Oncogene, 13, 2379-2386.
69. Morin, P.J., Vogelstein, B. and Kinzler, K. (1996) Apoptosis and APC in colorectal tumorigenesis. Proc. Natl Acad. Sci. USA, 93, 7950-7954.
70. Aoki, K., Yoshida, T., Matsumoto, N., Ide, H., Sugimura, T. and Terada, M. (1997) Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation. Mol. Carcinog., 20, 251-258.
71. Colomer, R., Lupu, R., Bacus, S.S. and Gelmann, E.P. (1994) erb-B2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erB-2 oncogene amplification. Br. J. Cancer, 70, 819-825.
72. Cannon, W.B. (1939) The Wisdom of the Body. W.W. Norton and Co. Inc., New York.
73. Nowell, P. (1976) The clonal evolution of tumor populations. Science, 194, 23-28.
74. Vishwanath, R., Iyer, V.R., Elsen, M.B., Ross, D.T., Schuler, G., Moore, T., Fee, J.C.F., Trent, J.M., Staude, L.M., Hudson, J., Bogusti, M.S., Lashkari, D., Shalon, D., Botstein, D. and Brown, P.O. (1999) The transcriptional program in the response of human fibroblasts to serum. Science, 283, 83-87.